Associations between obesity and the effectiveness of anti–tumor necrosis factor-α agents in inflammatory bowel disease patients: a literature review and meta …

Z Dai, X Xu, Z Ran - Annals of Pharmacotherapy, 2020 - journals.sagepub.com
Background: A total of 15% to 40% of adult inflammatory bowel disease (IBD) patients are
obese. The influence of obesity on anti-tumor necrosis factor-α (anti-TNF-α) treatment in IBD …
被引用次数：37 相关文章

Associations Between Obesity and the Effectiveness of Anti-Tumor Necrosis Factor-α Agents in Inflammatory Bowel Disease Patients: A Literature Review and Meta …

ZH Dai, XT Xu, ZH Ran - The Annals of pharmacotherapy, 2020 - pubmed.ncbi.nlm.nih.gov
Background: A total of 15% to 40% of adult inflammatory bowel disease (IBD) patients are
obese. The influence of obesity on anti-tumor necrosis factor-α (anti-TNF-α) treatment in IBD …

Associations Between Obesity and the Effectiveness of Anti-Tumor Necrosis Factor-α Agents in Inflammatory Bowel Disease Patients: A Literature Review and Meta …

ZH Dai, XT Xu, ZH Ran - The Annals of Pharmacotherapy, 2020 - europepmc.org
Background: A total of 15% to 40% of adult inflammatory bowel disease (IBD) patients are
obese. The influence of obesity on anti-tumor necrosis factor-α (anti-TNF-α) treatment in IBD …